HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$12.80
Day range
$12.41 - $12.95
Year range
$5.88 - $30.40
Market cap
1.19B USD
Avg Volume
63.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 25.22M | -13.99% |
Operating expense | 21.19M | -8.96% |
Net income | 3.53M | 90.39% |
Net profit margin | 13.99 | 121.36% |
Earnings per share | — | — |
EBITDA | 3.50M | -33.86% |
Effective tax rate | 24.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.10M | 13.24% |
Total assets | 120.93M | 8.73% |
Total liabilities | 27.58M | 102.45% |
Total equity | 93.35M | — |
Shares outstanding | 93.42M | — |
Price to book | 18.03 | — |
Return on assets | 6.71% | — |
Return on capital | 8.85% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 3.53M | 90.39% |
Cash from operations | -5.49M | -221.18% |
Cash from investing | -8.27M | -2.76% |
Cash from financing | 156.00K | — |
Net change in cash | -13.69M | -209.82% |
Free cash flow | -6.68M | — |
About
Founded
2002
Headquarters
Website
Employees
593
